Mechanisms and Therapeutic Strategies for HCV/HBV-Associated B-Cell Non-Hodgkin’s Lymphomas: A Viewpoint
Oncology Research · 2026
DOI: 10.32604/or.2025.071847 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Research, 2026. Verfasst von Guido Carloni und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Translational Pharmacology (IFT), Department of Biomedical Sciences (DBS), National Research Council (CNR), Rome, 00133, Italy. Hauptthemen laut MEDLINE: Lymphoma, B-Cell, Hepatitis B, Hepatitis C, Hepatitis C, Chronic. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Translational Pharmacology (IFT), Department of Biomedical Sciences (DBS), National Research Council (CNR), Rome, 00133, Italy.
Zitieren
APA
Carloni, G., & Rinaldi, M. (2026). Mechanisms and Therapeutic Strategies for HCV/HBV-Associated B-Cell Non-Hodgkin’s Lymphomas: A Viewpoint. Oncology Research. https://doi.org/10.32604/or.2025.071847
Vancouver
Carloni G, Rinaldi M. Mechanisms and Therapeutic Strategies for HCV/HBV-Associated B-Cell Non-Hodgkin’s Lymphomas: A Viewpoint. Oncology Research. 2026. doi:10.32604/or.2025.071847
BibTeX
@article{Carloni2026,
author = {Carloni, Guido and Rinaldi, Monica},
title = {Mechanisms and Therapeutic Strategies for HCV/HBV-Associated B-Cell Non-Hodgkin’s Lymphomas: A Viewpoint},
journal = {Oncology Research},
year = {2026},
doi = {10.32604/or.2025.071847}
}
EUVIMED